People channel feed

Ko­re­an bio­phar­ma ex­ec­u­tive in­dict­ed for al­leged­ly con­duct­ing il­le­gal tri­als on com­pa­ny re­searchers

6 years ago
Pharma

In the midst of a deal spree, Bay­er turns to vet­er­an J&J deal­mak­er Mar­i­anne De Backer to bring home the tech­nol­o­gy

6 years ago

Azar keen on nom­i­nat­ing Brett Giroir, di­vi­sive as­sis­tant HHS sec­re­tary, to top job at FDA — re­port

6 years ago
FDA+

Top FDA ex­ec Ed­ward Cox jumps ship and joins Re­gen­eron as new reg­u­la­to­ry VP

6 years ago
Pharma

Af­ter ink­ing a string of pipeline deals, Boehringer In­gel­heim is do­ing a makeover of the top ex­ec­u­tive team

6 years ago

‘Ab­solute stand­out’ bio­phar­ma an­a­lyst Mark Schoenebaum has died

6 years ago

Sir An­drew Dil­lon, NICE's first — and on­ly — chief ex­ec­u­tive to step down next year

6 years ago
Pharma
FDA+

MHRA to land a new in­ter­im chief ex­ec­u­tive ahead of Brex­it

6 years ago

AveX­is sci­en­tif­ic founder fires back at No­var­tis CEO Vas Narasimhan, 'cat­e­gor­i­cal­ly de­nies any wrong­do­ing'

6 years ago

Roche raids Eli Lil­ly for its next chief med­ical of­fi­cer as San­dra Horn­ing plans to step down

6 years ago

Sci­en­tist-CEO ac­cused of im­prop­er­ly us­ing con­fi­den­tial in­fo from uni­corn Alec­tor

6 years ago
Pharma

AveX­is sci­en­tif­ic founder was axed — and No­var­tis names a new CSO in wake of an ethics scan­dal

6 years ago

Pow­er­ful Re­pub­li­can Chuck Grass­ley at­tacks No­var­tis CEO Narasimhan for ‘rep­re­hen­si­ble’ de­ci­sion to hide da­ta

6 years ago

Trump's key drug pric­ing ad­vi­sor O'Brien makes HHS ex­it

6 years ago

Make that 2 new US Big Phar­ma chiefs to­day, as No­var­tis re­makes top team

6 years ago
Pharma

Shift­ing fo­cus to on­col­o­gy, GSK re­cruits a can­cer vet as new chief of US phar­ma­ceu­ti­cals — adding an­oth­er woman to the top ranks of bio­phar­ma

6 years ago

Key Ap­ple dig­i­tal health re­searcher set to join the Gates Foun­da­tion — re­port

6 years ago
R&D

Retrophin paid Mar­tin Shkre­li 'undis­closed sum' to set­tle years­long le­gal dis­putes

6 years ago

Melin­ta chief John John­son jumps ship — with the chair­man — from an­oth­er trou­bled an­tibi­otics play

6 years ago

Gilead­'s new­ly de­part­ed R&D chief re-emerges as CEO of a ri­val hep B biotech look­ing to make a come­back

6 years ago

Loxo chief Josh Bilenker steps in (tem­porar­i­ly) to head on­col­o­gy R&D at Eli Lil­ly as Levi Gar­raway steps out

6 years ago
Pharma

Te­va to lose CFO, with turn­around still un­der con­struc­tion

6 years ago
Pharma

Part pro­ce­dure, part drug: Robert Ang joins Sid­dhartha Mukher­jee in pi­o­neer­ing a new type of cell en­gi­neer­ing

6 years ago
Startups
Cell/Gene Tx

Join­ing Chang and Bellde­grun, Rafael Ama­do takes a lead­ing R&D post in the next big cell ther­a­py rev­o­lu­tion

6 years ago
Cell/Gene Tx
First page Previous page 74757677787980 Next page Last page
A service from the Financial Times